Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,763 | -197,614 | -143,589 | -97,329 | -38,992 |
| Depreciation Amortization | 1,502 | 2,972 | 1,904 | 1,312 | 1,086 |
| Accounts payable and accrued liabilities | -292 | 1,033 | 466 | 1,303 | 1,965 |
| Other Working Capital | -9,642 | 2,922 | 6,357 | 504 | -556 |
| Other Operating Activity | 10,703 | 39,111 | 30,929 | 20,712 | 6,174 |
| Operating Cash Flow | $-54,492 | $-151,576 | $-103,933 | $-73,498 | $-30,323 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -879 | -17,919 | -15,146 | -12,299 | -2,028 |
| Purchase Of Investment | -153,155 | -369,696 | -219,139 | -144,029 | -109,810 |
| Sale Of Investment | 140,701 | 535,327 | 339,612 | 212,162 | 103,791 |
| Investing Cash Flow | $-13,333 | $147,712 | $105,327 | $55,834 | $-8,047 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 195,913 | 6,190 | 4,156 | 3,477 | 908 |
| Financing Cash Flow | $195,913 | $6,190 | $4,156 | $3,477 | $908 |
| Beginning Cash Position | 80,949 | 78,623 | 78,623 | 78,623 | 78,623 |
| End Cash Position | 209,037 | 80,949 | 84,173 | 64,436 | 41,161 |
| Net Cash Flow | $128,088 | $2,326 | $5,550 | $-14,187 | $-37,462 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,492 | -151,576 | -103,933 | -73,498 | -30,323 |
| Capital Expenditure | -879 | -17,919 | -15,146 | -12,299 | -2,028 |
| Free Cash Flow | -55,371 | -169,495 | -119,079 | -85,797 | -32,351 |